Ven20novembre
Programma
- VENERDì 20 NOVEMBRE
- 08:00Participant Accreditation and ECM Attendance Tracking
- 08:45Welcome and Introduction
- Session 1: Beyond Primary and Secondary Prevention: The New LDL-C Paradigm
- Session 1: Beyond Primary and Secondary Prevention: The New LDL-C ParadigmVincenzo De Sio, Michele Fabrizio
- 09:00Lower, sooner, longer: Does it still make sense to distinguish between primary and secondary prevention?Paolo Cimaglia
- 09:13Statins and Ezetimibe: A complementary approach to dyslipidemic patientsMatteo Armillotta
- 09:26Bempedoic Acid: Evidence-based use and real-world dataPaolo Calabrò
- 09:39Flash Questions
- Session 2: Closing the LDL-C Gap in Patients at High and Extreme Cardiovascular Risk
- 10:00Before the Event: What the VESALIUS-CV Trial Teaches UsIlaria Cavallari
- 10:13PCSK9i in Acute Coronary Syndrome: The Sooner, the Better?Arturo Cesaro
- 10:26The first dose isn't enough: how to build treatment adherence and persistence with PCSK9 inhibitorsGiuseppe Musumeci
- 10:39Flash Questions
- 11:00Coffee Break
- Session 3: Residual Lipid Risk Beyond LDL-C
- 11:16Therapeutic Approach to Hypertriglyceridemia: Should We Aim to Achieve the Target and/or Reduce Residual Risk?Alberto Menozzi
- 11:29Lp(a): From Risk Modifier to Therapeutic TargetLuca Bergamaschi
- 11:42Hyperhomocysteinemia: risk factor or thrombotic risk marker? What about the treatment? A hematologist's perspectiveSimone Birocchi
- 11:55Flash Questions
- Best practice 2026
- Best practice 2026Lorenzo Spighi
- 12:21Residual Risk and Resistant Arterial Hypertension: the role of renal denervationMatteo Ziacchi
- 12:34Pulsed Field Ablation: The right procedure for the right patientDavide Saporito
- 12:47Flash Questions
- 13:00Light Lunch
- Session 4: Heart, kidneys, metabolism: a single risk. The new approach to cardio -renal-metabolic prevention
- Session 4: Heart, kidneys, metabolism: a single risk. The new approach to cardio -renal-metabolic preventionDaniela Lina, Matteo Serenelli
- 14:00ESC 2026 Guidelines: A New Roadmap for the Heart and KidneyMaddalena Lettino
- 14:13Before the damage: Early initiation of SGLT2 inhibitorsGiulia Magnani
- 14:26Closing the gap between diabetes and cardio-renal outcomes with semaglutideSilvia Zagnoni
- 14:39Flash Questions
- Session 5: Beyond Lipids: Inflammation, Immunity, and Cardiovascular Risk
- Session 5: Beyond Lipids: Inflammation, Immunity, and Cardiovascular RiskCarlo Biagetti, Elisabetta Tonet
- 15:00One Pathway, Many Diseases: The Role of Cardiovascular InflammationStefano Savonitto
- 15:13Residual Inflammatory Risk: Are We Prepared to Treat It?Raffaele De Caterina
- 15:26From Infection Prevention to Cardiovascular Protection: The Role of VaccinationsDaniele Grosseto
- 15:39Flash Questions
- New perspective
- New perspectiveGiovanni Pasanisi
- 16:00Lecture: Why does physical activity play a fundamental role in cardiovascular prevention?Giampiero Patrizi
- 16:15Flash Questions
- Session 6: Precision reperfusion: from thrombectomy to guided antithrombotic therapy
- Session 6: Precision reperfusion: from thrombectomy to guided antithrombotic therapyManfredi Arioti, Gianni Dall’ara, Marco Mennuni
- 16:20When the Thrombus Drives the Strategy: An Interactive Clinical CaseAndrea Munafò
- 16:33Device-Based Thrombectomy: When Does Technology Really Change Outcomes?Iginio Colaiori
- 16:46After PCI: From Standard Care to Personalized Antithrombotic TherapyFelice Gragnano
- 16:59Flash Questions
- 17:20Opening Ceremony
- 17:20Ricerca scientifica, innovazione e sostenibilità del SSN: Tavola Rotonda con le IstituzioniLorenzo Broccoli, Mario Melazzini, Tiziano Carradori, Francesco Zaffini
- 18:20Atbv legacy: A Story of Passion
- Assemblea